Granular Creatures

粒曼生物

+86-180-6253-9203

Language
- 中文
- English

Home page

Qizhi Fund | Liman’s Comprehensive Gene Knockout Solution Featuring “High-Throughput Capacity + Exceptional Cost-Effectiveness”: Cell Stock, Kits, Equipment, and Custom Services

2025-04-14

Previous Page:

Liman Collaboration | Liman’s Ubiquitination-Enrichment Antibody Products Bolster the Clinical Translation Potential of the SCASP-PTM Technology in Cell Reports

Next page:

Market Conference... Elem was invited to participate in the "2024 Annual Meeting of the Intelligent Drugs Committee of the Chinese Pharmaceutical Association"

2025 /

04-14

Classification:

Company News

Related Information

2025-04-18

Product Launch | “Ubiquitination-Enrichment Antibodies” in the Protein Degradation Drug Product Line [Save for Later]

Product Launch | “Ubiquitination-Enrichment Antibodies” in the Protein Degradation Drug Product Line [Save for Later]

2025-04-18

Liman Collaboration | Liman’s Ubiquitination-Enrichment Antibody Products Bolster the Clinical Translation Potential of the SCASP-PTM Technology in Cell Reports

Liman Collaboration | Liman’s Ubiquitination-Enrichment Antibody Products Bolster the Clinical Translation Potential of the SCASP-PTM Technology in Cell Reports

2025-04-14

Technical Feature | Decoding the Code of Intracellular Protein Interactions: The Value and Selection Strategies of Proximity-Labeling Techniques in Biological Research [Save]

Technical Feature | Decoding the Code of Intracellular Protein Interactions: The Value and Selection Strategies of Proximity-Labeling Techniques in Biological Research [Save]

Graneman Biotechnology (Wuhan) Co., Ltd.

Welcome to consult Elem's high-throughput CRISPR service.

86-180-7171-9206

services@elem-bio.com

Copyright © Elem Biotechnology (Wuhan) Co., Ltd.

All products are used for scientific research only and may not be used for medical diagnosis or drug treatment.

Elem Biotech is only sold to units/enterprise entities.

LM